# Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

> **NCT06785077** · NA · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 157 (estimated)

## Conditions studied

- Leukemia, Myeloid, Acute
- Myeloid Dysplasia
- Ovarian Epithelial Cancer

## Interventions

- **PROCEDURE:** buccal cells
- **PROCEDURE:** bone marrow cells
- **PROCEDURE:** peripheral blood cells
- **PROCEDURE:** bone marrow biopsy

## Key facts

- **NCT ID:** NCT06785077
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-02
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 157 (ESTIMATED)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06785077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06785077, "Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06785077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*